KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 Apr 17, 2024 7:00am EDT
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference Mar 18, 2024 5:24pm EDT
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance Mar 13, 2024 4:05pm EDT
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic Mar 11, 2024 4:05pm EDT
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin Mar 06, 2024 7:00am EST
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 Feb 21, 2024 7:00am EST
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference Nov 29, 2023 7:00am EST
KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System Nov 08, 2023 4:10pm EST
